论文部分内容阅读
文迪雅是新开发出来的针对病因的抗糖尿病药物,因能够明显地改善胰岛素抵抗,所以被冠以特殊的名字“胰岛素增敏剂”。该药物是由英国的葛兰素史克公司开发研制出来的,是我国第一个被批准用于在临床上治疗糖尿病的格列酮类药物,它
Avandia is a newly developed disease-specific antidiabetic drug with a special name of “insulin sensitizer” because it significantly improves insulin resistance. Developed by GlaxoSmithKline in the United Kingdom, the drug is the first glitazone drug in our country approved for the clinical treatment of diabetes